key articles
Prostate biopsy in patients with long-term use of indwelling bladder catheter
Wednesday, 13 October 2010- Acute urinary retention (AUR) is expected to occur in 2% to 39% men with benign prostatic hyperplasia. To date, no study has elucidated the effect of long-term use of indwelling bladder catheter...
Edited by: JV
Factors identified for bone risk in men on ADT
Tuesday, 12 October 2010- Androgen deprivation therapy (ADT) leads to decay of bone microarchitecture and is a predisposing factor in bone fragility and fracture in prostate cancer patients, according to Australian...
Edited by: JV
Fish-filled diet may cut prostate cancer mortality
Monday, 11 October 2010- Eating lots of fish may not protect men from developing prostate cancer, but it could reduce their risk of dying from the disease, a new review of the medical literature suggests.
"In the United...
Edited by: ES
Cytochrome 450 1B1 polymorphisms linked with response to docetaxel in CRPC patients
Friday, 1 October 2010- The selection of patients according to key genetic characteristics may help to tailor chemotherapy and optimize the treatment in Castration-Resistant Prostate Cancer (CRPC) patients. Functional...
Edited by: JV
Limited benefits of aggressive screening and treatment for men with low PSA level
Thursday, 30 September 2010- With the benefits of prostate cancer screening on an individual level remaining unevaluated, a group of researchers examined the harms and benefits of early detection of prostate cancer (PCa). P. van...
Edited by: JV
Hormonal therapy before brachytherapy: no long-term effects on PCa patient's urinary function
Wednesday, 29 September 2010- Dutch researchers J. Evers and colleagues prospectively investigated the influence of 3-month neoadjuvant hormonal therapy (NHT) before brachytherapy (BT) for low-risk prostate cancer (PCa) on...
Edited by: JV
Cholesterol drug may have role in treating prostate cancer, says Canadian study
Wednesday, 22 September 2010- A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research.
Rosuvastatina statin drug sold as Crestor suppressed the...
Edited by: JV
Insurance status impacts severity of prostate cancer at diagnosis in US
Tuesday, 21 September 2010- According to an report just appearing online in the journal Cancer Epidemiology Biomarkers and Prevention, US prostate cancer patients who are uninsured or on Medicaid at the time of diagnosis...
Edited by: ES
Risks outweighs benefits of prostate screening in men with low PSA, says Dutch study
Friday, 17 September 2010- Men with low prostate-specific antigen (PSA) values may face more risks than benefits from aggressive approaches to prostate cancer screening and evaluation -- along with potential overtreatment –...
Edited by: JV
Link between PSA and PCa risk: the Prostate Biopsy Collaborative Group study
Monday, 13 September 2010- The relationship between prostate-specific antigen (PSA) level and prostate cancer risk remains subject to fundamental disagreements. A group of US researchers conducted a study to hypothesised that the...
Edited by: JV
